Trade Mark Journal No.2026/038 18 September 2026

WO0000001935703 (5)

Office of origin: United States of America

Date of International Registration:7 August 2026
Date of designation in the UK: 7 August 2026
Image for mark 1935703 LIFZANGO

International priority date claimed: 26 June 2026 (United States of America) (99907336)
Class 5
Pharmaceutical preparations for the prevention and treatment of obesity; pharmaceutical preparations for the prevention and treatment of metabolic and endocrine diseases and disorders.

Kailera Therapeutics, Inc.

Representative: Gabriel M. Gillmeyer Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston MA 02199, UNITED STATES OF AMERICA